A prospective study to evaluate efficacy and safety of low dose fenfluramine in Belgian patients with Dravet syndrome

Trial Profile

A prospective study to evaluate efficacy and safety of low dose fenfluramine in Belgian patients with Dravet syndrome

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Dec 2016

At a glance

  • Drugs Fenfluramine (Primary)
  • Indications Dravet syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Zogenix
  • Most Recent Events

    • 06 Dec 2016 Results presented at the 70th Annual Meeting of the American Epilepsy Society
    • 05 Dec 2016 Updated results published in the Zogenix Media Release.
    • 05 Dec 2016 According to a Zogenix media release, data from this study were presented at the 70th Annual American Epilepsy Society (AES) meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top